Literature DB >> 20210752

Computational methods for de novo protein design and its applications to the human immunodeficiency virus 1, purine nucleoside phosphorylase, ubiquitin specific protease 7, and histone demethylases.

M L Bellows1, C A Floudas.   

Abstract

This paper provides an overview of computational de novo protein design methods, highlighting recent advances and successes. Four protein systems are described that are important targets for drug design: human immunodeficiency virus 1, purine nucleoside phosphorylase, ubiquitin specific protease 7, and histone demethylases. Target areas for drug design for each protein are described, along with known inhibitors, focusing on peptidic inhibitors, but also describing some small-molecule inhibitors. Computational design methods that have been employed in elucidating these inhibitors for each protein are outlined, along with steps that can be taken in order to apply computational protein design to a system that has mainly used experimental methods to date.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20210752      PMCID: PMC2894634          DOI: 10.2174/138945010790711914

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  190 in total

1.  Short constrained peptides that inhibit HIV-1 entry.

Authors:  Samuel K Sia; Peter A Carr; Andrea G Cochran; Vladimir N Malashkevich; Peter S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

2.  Protein design is NP-hard.

Authors:  Niles A Pierce; Erik Winfree
Journal:  Protein Eng       Date:  2002-10

3.  Thoroughly sampling sequence space: large-scale protein design of structural ensembles.

Authors:  Stefan M Larson; Jeremy L England; John R Desjarlais; Vijay S Pande
Journal:  Protein Sci       Date:  2002-12       Impact factor: 6.725

4.  Prediction of beta-sheet topology and disulfide bridges in polypeptides.

Authors:  J L Klepeis; C A Floudas
Journal:  J Comput Chem       Date:  2003-01-30       Impact factor: 3.376

5.  Design and evaluation of sifuvirtide, a novel HIV-1 fusion inhibitor.

Authors:  Yuxian He; Yonghong Xiao; Haifeng Song; Qing Liang; Dan Ju; Xin Chen; Hong Lu; Weiguo Jing; Shibo Jiang; Linqi Zhang
Journal:  J Biol Chem       Date:  2008-02-26       Impact factor: 5.157

6.  Design of a novel HIV-1 fusion inhibitor that displays a minimal interface for binding affinity.

Authors:  Shinya Oishi; Saori Ito; Hiroki Nishikawa; Kentaro Watanabe; Michinori Tanaka; Hiroaki Ohno; Kazuki Izumi; Yasuko Sakagami; Eiichi Kodama; Masao Matsuoka; Nobutaka Fujii
Journal:  J Med Chem       Date:  2008-01-16       Impact factor: 7.446

7.  The ARID domain of the H3K4 demethylase RBP2 binds to a DNA CCGCCC motif.

Authors:  Shengjiang Tu; Yu-Ching Teng; Chunhua Yuan; Ying-Ta Wu; Meng-Yu Chan; An-Ning Cheng; Po-Hsun Lin; Li-Jung Juan; Ming-Daw Tsai
Journal:  Nat Struct Mol Biol       Date:  2008-02-12       Impact factor: 15.369

8.  Mutations affecting the oligomerization interface of G-protein-coupled receptors revealed by a novel de novo protein design framework.

Authors:  Martin S Taylor; Ho K Fung; Rohit Rajgaria; Marta Filizola; Harel Weinstein; Christodoulos A Floudas
Journal:  Biophys J       Date:  2008-01-04       Impact factor: 4.033

Review 9.  Development of transition state analogues of purine nucleoside phosphorylase as anti-T-cell agents.

Authors:  Vern L Schramm
Journal:  Biochim Biophys Acta       Date:  2002-07-18

10.  Algorithm for backrub motions in protein design.

Authors:  Ivelin Georgiev; Daniel Keedy; Jane S Richardson; David C Richardson; Bruce R Donald
Journal:  Bioinformatics       Date:  2008-07-01       Impact factor: 6.937

View more
  8 in total

1.  Free energies for coarse-grained proteins by integrating multibody statistical contact potentials with entropies from elastic network models.

Authors:  Michael T Zimmermann; Sumudu P Leelananda; Pawel Gniewek; Yaping Feng; Robert L Jernigan; Andrzej Kloczkowski
Journal:  J Struct Funct Genomics       Date:  2011-06-15

2.  Multibody coarse-grained potentials for native structure recognition and quality assessment of protein models.

Authors:  Pawel Gniewek; Sumudu P Leelananda; Andrzej Kolinski; Robert L Jernigan; Andrzej Kloczkowski
Journal:  Proteins       Date:  2011-04-19

Review 3.  Bioprospecting of microbial enzymes: current trends in industry and healthcare.

Authors:  Eswar Rao Tatta; Madangchanok Imchen; Jamseel Moopantakath; Ranjith Kumavath
Journal:  Appl Microbiol Biotechnol       Date:  2022-03-07       Impact factor: 4.813

4.  Rigorous Computational and Experimental Investigations on MDM2/MDMX-Targeted Linear and Macrocyclic Peptides.

Authors:  David J Diller; Jon Swanson; Alexander S Bayden; Chris J Brown; Dawn Thean; David P Lane; Anthony W Partridge; Tomi K Sawyer; Joseph Audie
Journal:  Molecules       Date:  2019-12-14       Impact factor: 4.411

Review 5.  Anurans against SARS-CoV-2: A review of the potential antiviral action of anurans cutaneous peptides.

Authors:  Marjoriane de Amaral; Julia Ienes-Lima
Journal:  Virus Res       Date:  2022-04-14       Impact factor: 6.286

6.  New compstatin peptides containing N-terminal extensions and non-natural amino acids exhibit potent complement inhibition and improved solubility characteristics.

Authors:  Ronald D Gorham; David L Forest; George A Khoury; James Smadbeck; Consuelo N Beecher; Evangeline D Healy; Phanourios Tamamis; Georgios Archontis; Cynthia K Larive; Christodoulos A Floudas; Monte J Radeke; Lincoln V Johnson; Dimitrios Morikis
Journal:  J Med Chem       Date:  2014-12-29       Impact factor: 7.446

7.  Forcefield_NCAA: ab initio charge parameters to aid in the discovery and design of therapeutic proteins and peptides with unnatural amino acids and their application to complement inhibitors of the compstatin family.

Authors:  George A Khoury; James Smadbeck; Phanourios Tamamis; Andrew C Vandris; Chris A Kieslich; Christodoulos A Floudas
Journal:  ACS Synth Biol       Date:  2014-01-14       Impact factor: 5.110

Review 8.  Synthetic biology for the directed evolution of protein biocatalysts: navigating sequence space intelligently.

Authors:  Andrew Currin; Neil Swainston; Philip J Day; Douglas B Kell
Journal:  Chem Soc Rev       Date:  2015-03-07       Impact factor: 54.564

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.